Home » Topics » Science » New compound

New compound
RSS

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Jan. 21, 2022

MCC-1381, a pan-HDAC inhibitor with promising anticancer activity

Jan. 18, 2022

Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis

Jan. 10, 2022

MCUF-651, a GC-A PAM for the treatment of cardiovascular, renal and metabolic diseases

Jan. 5, 2022

Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance

Dec. 29, 2021

MCC-1734 inhibits cancer cells with different resistance mechanisms

Dec. 21, 2021

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

Dec. 20, 2021

Discovery of long-acting entecavir prodrugs

Dec. 16, 2021

ASP-8731 inhibits microvascular stasis in models of sickle cell disease

Dec. 15, 2021

BCL6 PROTAC degrader ARVN-71228 shows efficacy in preclinical models of DLBCL

Dec. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...